Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Jonathan H Sussman und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Glioma, Brain Neoplasms, Single-Cell Analysis. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health/National Cancer Institute, NCI NIH HHS, University of Pennsylvania.
Abstract (Originalsprache)
Background
Solid tumor immune suppression requires cooperation of tumor cells, local immune cells, peripheral circulating immune cells, and evolution of immune cell trajectories between peripheral and local environments. This study addresses a significant knowledge gap by characterizing peripheral and local immune environments in isocitrate dehydrogenase (IDH) Mutant (IDH-Mut) and IDH wildtype (IDH-WT) gliomas and defines novel immunological states with prognostic relevance across the glioma landscape.
Methods
We analyzed local and peripheral immune phenotypes in a cohort of 18 (6 IDH-Mut and 12 IDH-WT) gliomas with distinct genetic characteristics using paired human tumor and peripheral blood mononuclear cells (PBMCs) with single-cell RNA-sequencing (scRNA-seq).
Results
Our analyses revealed unique intratumoral and peripheral immune cellular ontogenies, including naïve CD4+ T cell enrichment in the IDH-Mut peripheral immune compartment, monocyte enrichment in IDH-WT glioma PBMCs, and emergence of a unique population of GZMH+ CD8+ T cells preferentially in the IDH-Mut microenvironment. Additionally, we found upregulation of TNF-α signaling and inflammatory response pathways in IDH-Mut-glioma-associated peripheral lymphoid cells versus IDH-WT tumors and identified a novel population of microglia-like cells in the peripheral blood of glioma patients with complement-interfacing characteristics. Applying intratumoral transcriptomic deconvolution via The Cancer Genome Atlas revealed genotype-independent, prognostic immune signatures across the malignant glioma landscape.
Conclusions
This study reveals variable expression of immune phenotypes in adult gliomas stratified by IDH status and characterizes immune compartment and genotype-dependent differences in the immunologic glioma landscape. These genotype-dependent, tumor and circulating immune ontogenies should guide future diagnostic and immunotherapeutic considerations in malignant glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
- Center for Systems Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Graduate, Group in Cellular and Molecular Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Jonathan H Sussman, Nduka M Amankulor
Förderung
- National Institutes of Health/National Cancer Institute
- NCI NIH HHS
- University of Pennsylvania
- NIH HHS
- NIGMS NIH HHS
- University of Pittsburgh
- University of Pennsylvania (startup funds to N.M.A.); and Keim Family Foundation
Zitieren
APA
Sussman, J. H., Cillo, A. R., Kohli, S., Cardello, C., Patterson, J., Akca, E., Angione, A., Moon, D., Krueger, K., Ghamari, A., Xu, E., Xu, J., Tarbay, A. C., Li, A., Budihal, B. R., Zhang, X., Elghawy, O., Panek, W. K., Rajappa, P., …, & Amankulor, N. M. (2025). Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf206
Vancouver
Sussman JH, Cillo AR, Kohli S, Cardello C, Patterson J, Akca E, et al. Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf206
BibTeX
@article{Sussman2025,
author = {Sussman, Jonathan H and Cillo, Anthony R and Kohli, Sajeev and Cardello, Carly and Patterson, Jonathan and Akca, Ebrar and Angione, Angelo and Moon, David and Krueger, Katharine and Ghamari, Ali and Xu, Emily and Xu, Jessica and Tarbay, Antonio C and Li, Alex and Budihal, Bhargavi R and Zhang, Xiaoran and Elghawy, Omar and Panek, Wojciech K and Rajappa, Prajwal and Tan, Kai and Vignali, Dario A A and Bruno, Tullia C and Amankulor, Nduka M},
title = {Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf206}
}
EUVIMED